Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 13 Projects
Project # Contact PI Funding Organization Fiscal Year
Open-label Clinical Trial of Nabilone for Neuropsychiatric Symptoms in Frontotemporal Dementia
ADDF-34 Ducharme, Simon Alzheimer's Drug Discovery Foundation 2021
Nabilone for Agitation Blinded Intervention Trial (NAB-IT)
GC-201808-2016354 Lanctôt, Krista Alzheimer's Drug Discovery Foundation 2018
Prevention of cognitive decline in older adults with low DHA/EPA index in red blood cells (Acronym : MAPT 2)
GC-2012941 Vellas, Bruno Alzheimer's Drug Discovery Foundation 2016
Apports d'une thérapie sémantique sur tablette tactile dans la maladie d'Alzheimer, formes jeunes et tardives. IngentaConnect Alzheimer's Disease and Alzheimer's Disease
EUJPND-DGOS-FERRIEUX-696 FERRIEUX, Sophie La direction générale de l'Offre de soins (DGOS) 2016
Neuroprotective, motor and cognitive impact of prolonged high intensity aerobic work in Parkinson's disease. Comparison of two exercise intensity training programs with a different intensity and a conventional physiotherapy program for 9 months
EUJPND-DGOS-GRACIES-700 GRACIES, Jean-Michel La direction générale de l'Offre de soins (DGOS) 2016
Démence en EHPAD: Télémédecine pour la prise en Charge des Troubles psycho-comportementaux. Dementia in EHPAD: Telemedicine for the Management of Psycho-Behavioral Disorders
EUJPND-DGOS-SOTO MARTIN-716 SOTO MARTIN, Maria La direction générale de l'Offre de soins (DGOS) 2016
Safety & Efficacy of nabilone in institutionalized patients with Alzheimer's Disease: a pilot study
20140503-LANCTOT-2014 LANCTOT, KRISTA L. Alzheimer's Drug Discovery Foundation 2014
ADD ON: Sartans to Slow Alzheimer's Disease: A Randomized, Open-Label, Head-to-Head, Proof-of-Concept Study of Angiotensin Receptor Blockers Versus ACE Inhibitors in Hypertensive Mild-Moderate AD Patients using Ventricular Enlargement as Primary Outcome
20141208-BLACK-2014 Black, Sandra Alzheimer's Drug Discovery Foundation 2014
Sartans to Slow Alzheimer's Disease: A Randomized, Open-Label, Head-to-Head, Proof-of-Concept Study of Angiotensin Receptor Blockers Versus ACE Inhibitors in Hypertensive Mild-Moderate AD Patients using Ventricular Enlargement as Primary Outcome
20121211-BLACK-2013 Black, Sandra Alzheimer's Drug Discovery Foundation 2013
Novel modulators of apoE function
290102.01-WELLINGTON-2012 WELLINGTON, CHERYL LEA Alzheimer's Drug Discovery Foundation 2012